AGENDA of the 2nd International Scientific Meeting on Hematology, Oncology, Thrombosis & Transplantation /

Transfusion in Indonesia 2016 (the 2nd ISMI-HOTTI 2016 ), Grand Sahid Jaya Hotel Jakarta
Day 1. Friday, December 09th , 2016
07.30 - Registration
ROOM ! ROOM 2 ROOM 2 ROOM 3 ROOM 4 ROOM 5 ROOM 1 ROOM 7
Puri Ratna Candi Singosari Candi Singosari CandiPawon1+2 Candi Bentar Candi Kalasan 1 Puri Ratna Candi Kalasan 2
TUTORIAL 1 A SEMINAR 1 SEMINAR 1 TUTORIAL 2 A TUTORIAL 3 A TUTORIAL 4 A TUTORIAL 1 A TUTORIAL 6 A
1.MF/FKUI:Research ThailandIndone 1.MF/FKUI- 1. Residents New Internist Laboratory 1. Nurses (N) and MF/FKUI Research &
& Development Cen sia Networking RSCM: Healthy 2. Trainees Fellow Oncology doctors, labora Midwifes (M) of Development Center
ter of Transfusion (THIN)&Thalasse Jakarta Program 3. Consultants Program (DKI tory scientists, Referral Hospitals in of Transfusion
Medicine plus mia International (HJP): the2nd 4. Internist Fellow Jakarta Raya and laboratory DKI Jakarta Raya (by Medicine:
Education program: Federation (TIF): health care Oncology/IFO of throughout technicians of invitation) and thro 1. S2 Master Science
a. Internship pro 1. Attendees by strengthening/ Hematology-Medi Indonesia): referral hospitals: ughhout Indonesia Transfusion Students
gram (IP):Pre-/Post- invitations of Urban health pro cal Oncology/of a. Selected 1. in DKI Jakarta 2. Oncology nurses 2. Master of Trans
program of DKI THIN/TIF gram (UHP) Hematology Onco attendees Raya (ON) fusion Medicine
Jakarta Raya: by 2.Specialists(SPEC) 2. Referral Hospi logy Pediatrics/of b. Attendees by 2. throughout 2. Apheresis nurses Technology (MTMT):
invitation : Internists, tals throughout Clinical Pathology invitation Indonesia (AN) a. Additional program
2. General practitio pediatricians, Indonesia (RHI) /others) 3. Others 3. Circumcision 3. Selected attendees
ners (GP) others 3.PKK-DKIJakarta nurses (CN)
(IP & GP) (THIN/TIF-SPEC) (HJP-RHI-PKK) (RETCIFHO) (New-IFONIFO) (LAB) (N)(M)(ON)(AN)(CN) (MTMT)
08.00 IP & GP Session 1: THIN-TIF SEMINAR 1 A Session1 RETCFHOSession1 NIFO Session 1 LAB Session 1 NMIP&GP Session1 MTMT Session 1
Safe &appropriate Thalassemia control program: Anti hemophilia Systemictherapy Hb-pathy, Safe & appropriate Medical Faculty.
09.00
use of blood transf. factors in hematological (Module1) use of blood University Indonesia:
1. Problems in Indonesia in
in daily practice 1. When patients and solid tumor 1. Molecular basis transfusion in daily Research program
(SATB, Module 1)
a. children: Dr dr Pustika Amalia with hemophilia cancers (STHSC, of hemoglobinopa practice (SATB, Session 1
1.Cold chain in safe b. in adult; Dr dr Tb Djumhana need antihemo Module 1) this (thalassemias Module 1): 1. Cold 1. Main topics of
blood donor supply Atmakusuma philia factors & by Basic principles of & Hb-variants) chain in safe blood research in UI
2.Donorconditions, 2. Health office of DKI Jakarta Raya passing agents? cancer diagnosis: 2. Laboratory donor supply, 2. Do 2. Research grants of
collections, compli Plain of action: dr Koesme di 2. How to give Clinical, lab (histo screening tests nor conditions,collect FKUI, RSM, UI, Kemen
cations, 3. Donor Priharto, SpOT, MKes appropriately logy, chemistry), 3. Case studies ions, complications ristekdik, others
counseling (dr (Dr dr Lugyanti S) staging/imaging 3.Donor counseling (Dr dr Budi Wiweko)
Adytia)
3. Q & A
09.00 IP & GP Session 2: THIN-TIF SEMINAR 1 B Session 2 RETCFHO Session- NIFO Session 2 LAB Session 2 NM -> IP & GP MTMT Session 2
(SATB, Module 2) Strategy & POA, Ministry of 2(Anticoagulant1) (STHSC,Module 2) Hb-pathy: (SATB, Module 2) Medical Faculty.
10.00
1.Blood donor hand Health, Republic Indonesia in 1. When we give Basic principle of (Module 2) 1. Blood donor hand University Indonesia:
ling: ABO-Rh typing, heparin (UFH/ main modality in 1.Laboratory diag ling: ABO-Rh typing, Research program
thalassemia control program in
cross-matching, in LMWH)2. When is cancer treatment: nosis of -thalasse cross-matching, Session 2.
compatible results,
Indonesia : 1. Directorate General HIT suspected? If a. types (surgery, mias& Hb variants incompatible results, 1.Biomedics PhD
TTI(transfusion tran of Diseases Prevention & Control occurs, what the radiotherapy, , by HPLC & mini TTI tests, donor program in Medical
smitted infection), 2. Directorate General of Health options.3.What systemic therapy) capillary electro blood separation, Faculty UI
blood separation, Services anticoagulants b. objectives phoresis storage, release 2. How to develop
storage, release 3. Directorate General o Pharmacy used as a bridging (curative, pallia 2. Case studies 2. Blood products proposals of S3
 2. Blood products and Health Equipment therapy? (Dr dr Lu tive), end of life (Prof Dr Franciscus
(Dr dr Ni Ken Ritchi) 4. Q & A gyanti Sukrisman)
10.00- Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area)
10.15
ROOM ! ROOM 2 ROOM 2 ROOM 3 ROOM 4 ROOM 5 ROOM 1 ROOM 7
Puri Ratna Candi Singosari Candi Singosari Candi Pawon 1 + 2 Candi Bentar Candi Kalasan 1 Puri Ratna Candi Kalasan 2
TUTORIAL 1 A SEMINAR 1 B SEMINAR 1 B TUTORIAL 2 B TUTORIAL 3 B TUTORIAL 4 A TUTORIAL 1 TUTORIAL 6 B
IP & GP THIN/TIF-SPEC HJP-RHI-PKK RETCIFHO NIFO LAB NM,ON,AN MTMT
10.15 IP & GP Session 3 THIN-TIF SEMINAR 1 C Session RTCFHO Session 3 NIFO Session 3 LAB Session 3 NMIP&GP Session MTMT Session 3
(SATBP, Module 3) (Anti-coagulant2) (STHSC,Module 3) (Hb-pathy 3 (SATBP, Module 3) Module1: Hemato
11.15 3.
1. Flowchart, SOP, 1. How to monitor (STHSC,Module 2) Module 2) 1. Flowchart, SOP, poietic stem cell
documents.2. Pati Thalassemia control program: UFH or LMWH : Basic principle of 1. Molecular documents banking:1.Bone ma
ents blood handling 1. Thailand strategy (Prof aPTT ? anti-Xa? medical oncolo diagnosis of - 2. Patients blood rrow,peripheral,blood
3. Blood transfusion Suthat Fucharoen, PhD) 2. If bleeding com gy: Systemic the thalassemias handling stem cell, umbilical
ion practice in hospi plication occurs, rapy, supportive 2. Case studies 3. Blood transfusion cord blood: handling,
2.Thalassemia International
tal wards; what the antidote th/, palliative (Prof Pranee, practice processing,storage,
dr Anna Mira Lubis Federation (TIF) (Dr Michael 3. Case studies care, hospice care Thailand) 4. Case studies transport, thawing
Angastiniotis) (Cyprus) (Dr dr Djumhana) 2. Dr Iswari S (JKT) (dr Auda Azis,SpKTp
11.15 IP & GP Session 4 THIN-TIF SEMINAR 1 D RTCFHO Session 4 NIFO Session 4 LAB Session 4 NIP & GP Session 4 MTMT Session 4
( SATBP, Module 4) (Anticoagulant 3) (STHSC,Module 4) (Hb-pathy Approach of bleeding Module 2:
12.00 Session 4
1. Approach of Venous Thrombo Basic principle of Module 3) until hemophilia is 1. Hemato poietic
bleeding until Panel discussion embolism (VTE): systemic therapy: 1. Laboratory diagnosed,treatment, stem cell banking
hemophilia is diag 1. Acute DVT&PE : Cytotoxic chemo diagnosis of - transfusion, emergen 2. BM, PBSC, UCB
THIN-TIF
nosed, treatment, Diagnosis & mana therapy, targeted, thalassemia cy conditions banking enume
emergency gement in acute hormonal, 2. Case studies (SATBP, Module 8) ration, viability,
conditions and phase? 2.NOAC vs biological therapy (Dr dr Ina S sterility,toxicology
transfusion LMWH based on Timan) 1. dr Auda S Aziz ,
(Dr dr Novie Chozie guidelines & scien (dr Halida Hara SpKTp
Amalia) tific evidence? hap, PhD) (Dr dr 2. dr Yanto, MBiomed
(Prof Dr Karmel T) Diana Aulia)
12.00 FRIDAY PRAYER (SAHID MOSQUE/Puri Ratna Gate) and LUNCH TIME (Pre function of Candi Singosari & Candi Bentar)
13.00
ROOM ! ROOM 2 ROOM 2 ROOM 2 ROOM 4 ROOM 5+7 ROOM 2 ROOM 2
Puri Ratna Candi Singosari Candi Singosari Candi Singosari Candi Bentar Candi Kalasan 1+2 Candi Singosari Candi Singosari
TUTORIAL 1 A SYMPO 1 A + B SYMPO 1 A + B SYMPO 1 A + B TUTORIAL 3 C TUTORIAL 4 B SYMPO 1 A + B SYMPO 1 A + B
IP & GP THIN-TIF-SPEC HJP-RHI RETCFHO NIFO LAB NM MTMT
13.00 IP&GP Session 5 THIN-TIF Session 5 : NIFO Session 5: LAB Session 5 NM TIN-TIF MTMT TIN-TIF
(SATBP, Module 5) (STHSC,Module5) MIC tests for Session 5 Session 5
14.00 Symposium 1 A
Appropriate use of Adverse reaction acute leukemias Symposium 1 A Symposium ! A
blood transfusion in HbE, & HbE/- thalassemias toxicities, (Module 1) HbE, , HbE/- HbE, & HbE/-
 1. Surgical bleedings 1. Genotype & phenotype comparison: Tbd prevention, 1. Morphology & thalassemias thalassemias
Tbd (traumatology) treatment cytochemistry 1. Genotype & phe 1. Genotype & phe
2. FAB classificati notype comparison notype comparison
2.Obstetric 2. Blood transfusion in HbE/B Thalassemia ons of AML 2. Blood transfusion 2. Blood transf in
bleedings: Dr dr Ali 3 ALLClassification in HbE/B Thal: TDT HbE/B Thal: TDT
of TDT?: Tbd
sungkar 4. Case studies
(Prof dr Riady W)
14.00 IP&GP Session 6 THIN-TIF Session 2: NIFO Session 6: LAB Session 6 NM TIN-TIF MTMT TIN-TIF
(SATBP, Modul 6) (STHSC,Module 6) MIC tests for Session 6: Session 6
15.00 Symposium 1 B
1. Complications of Assessment pre acute and chronic Symposium 1 B Symposium 1 B
blood transfusion HbE, & HbE/- thalassemias administration: leukemias , HbE & HbE/- HbE, & HbE/-
2. Treatment & Diagnosis review, (Module 2) thalassemias thalassemia
1. Iron overload complications: tbd
prevention: Dr dr Tb organ function, 1. Cytogenetic 1. Iron overload 1. Iron overload
Djumhana A 2. Bone marrow transplantation: tbd PS,BSA,dose adj 2. Case studies complications complications
Dr dr ikhwan ustment, time out Prof Dr dr Aru Sud 2. Bone marrow 2. Bone marrow
Rinaldy oyo,, SpPD, KHOM transplant transplant
15.00 Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area)
15.15
ROOM ! ROOM 2 ROOM 2 ROOM 2 ROOM 4 ROOM 5+7 ROOM 1 ROOM 5+7
Puri Ratna Candi Singosari Candi Singosari Candi Singosari Candi Bentar Candi Kalasan 1+2 Puri Ratna Room Candi Kalasan1+2
TUTORIAL 1B SYMPO 1 C + D SYMPO 1 C + D SYMPO 1 C + D TUTORIAL 3 D TUTORIAL 4 C TUTORIAL 1 B TUTORIAL 4 C
IP & GP THIN-TIF-SPEC HJP - RHI RETCFHO NIFO LAB NM, CN MTMT
15.15 - IP&GP Session 7 THIN-TIF Session 3 NIFO Session 7: LAB Session 7 NM IP & GP MTMT LAB Session
(SATBP, Module 7) (STHSC,Module 7) Flowcytometry: Approach of anemia 7
16.15 Symposium 1 C
1. Approach of 1. Administration 1. Specimen hand until thalassemia is Flowcytometry:
anemia until thalas HbE, & HbE/- thalassemias monitoring ling & preparation diagnosed,treatment, 1. Specimen handling
semia is diagnosed 2. Flowchart, SOP, 2. A proper gating transfusions, emerg & preparation
1. Other complications (other than iron
treatment, emer documents procedure & pro eency conditions 2. A proper gating
gency conditions overload): Tbd 3. Cross talk blems in gating & (SATBP, Module 7) procedure &
2. safe & optimal 2. Thrombosis complications: Tbd between nurses & how to overcome problems in gating &
blood transfusion in med oncologists 3. Q & A how to overcome
thalassemiaTDT Dr (Prof Kovit P) 3. Q & A
dr Pustika Amalia (Prof Kovit P)
16.15 IP & GP Session 8 THIN-TIF Session 4 NIFO Session 8 LAB Session 8: NM IP & GP MTMT LAB
(SATBP, Module 8) (STHSC,Module 8) Flowcytometry & IP & GP Session 8 Session 8
17.15 Symposium 1 D
Appropriates use of = Cytotoxic Leukemia Module ( SATBP, Module 4) Flowcytometry &
blood transfusion: HbE, & HbE/- thalassemias handling 3: 1. MIC for Appropriates use of Leukemia Module3
1. in GIT bleeding. Case studies: HbE homozygote , B-thalassemia major, = Cross-talk bet acute leukemias blood transfusion: 1.a. Leukemia MIC &
Dr dr Ary Fachrial HbE/B-thalassemia transfusion dependent (TDT) & ween pharmacists 2. Minimal resi 1. in GIT bleeding MRD
2. in thrombocy non transfusion dependent thalassemia (NTDT) & medical onco dual diseases 2. in thrombocyte 1. b. in others & CD
topenia ec DHF, DIC 1. dr wulyo rajabto, dr Anna Mira Lubis, dr Rachmat logists/ IFO (MRD) penia ec DHF, DIC 34+ stem cells
Dr dr Andhika 2. Case studies 3. Case studies 2. Case studies
Cayanur)
Rachman (Dr dr Agus K) (Dr dr Agus Kosasih)
17.15 End of day 1 scientific meeting

Day 1, Friday, November 09, 2016 Parallel Program Topics

13.00 17.00 Room 6, SEMINAR 2 : National Cross-talk between Hemophilia Experts, Hospitals and Problems in the management of hemophilia patients: Patient demands,
Candi Dieng 1 + 2 Policy makers hospital problems, authority regulations> How to overcome these?
13.00 16.00 Room 3: Business meeting 3: PKK DKI Jakarta Raya Business Meeting Vision, mission, strategic issues and plan of action (POA) in 2017 and 2018
Candi Pawon 1 + 2
18.00 18.30 Candi Singosari Inauguration of the Indonesian Society of Hematology and Transfusion Medicine (National /Central ISHTM, Branches and Commissions of ISHTM

Dinner symposium-2 and Business meeting-2

18.30 Room 2 DINNER SYMPOSIUM 1 Update on appropriate and optimum use of iron chelating agents in thalassemia patients with iron toxicity
19.30 Candi complications in the liver and the heart ?
Singosari Dr Fernando Tricta, PhD (Brazil/Canada)
Room
19.30 BUSINESS MEETNG-1 How to Establish a Center of Excellence in Thalassemia in SEA countries
22.45
Topics What has the Ministry of Health of RI done in the thalassemia control program ? (top up package, etc )
How does the Association of Southeast Asian Nations (ASEAN) support & HbE/-thalassemia control program in the Southeast Asian
countries?
What has Indonesia done in thalassemia control program?:
1. The Dean of the Medical faculty , Uiniversity Indonesia: Education program in the Secondary and Primary Health Care Facilities
2. The President Director / CEO of Dr Cito Mangunkusumo National General Hospitals
Laboratory? Healthy Jakarta Program? Thalassemia registry? Education ?
What has Indonesia learned from Thailand in establishing thalassemia diagnosis, management and prevention program of thalassemias?
How is it Thailand become a leader and center of excellence in research, registry, prevention, education, reference & referral laboratory
and management, including BMT of -thalassemia major & HbE/- thalassemia ?
Any suggestions from TIF for Indonesia in developing and establishing Thalassemia Control program

Goals Thailand is a center of excellence in HbE/-Thalassemia control program and Indonesia (other countries in Southeast Asia as well) is a partner of
this center in Southeast Asia; Vision, Mission, Strategic issues and plan of action (POA) in 2017 - 2022 of ASEAN and Ministry Health of Thailand and
Indonesia
Day 2. Saturday, December 10th , 2016
07.30 - Registration
ROOM ! ROOM 1 ROOM 1 ROOM 2 ROOM 2 ROOM 2 ROOM 4 ROOM 7
Puri Ratna: Puri Ratna Puri Ratna Candi Singosari Candi Singosari Candi Singosari Candi Bentar Candi Kalasan 2
TUTORIAL 1 C TUTORIAL 1 C TUTORIAL 1 C SYMPOSIUM 2 SYMPOSIUM 2 SYMPOSIUM2 TUTORIAL 3 E TUTORIAL 6 C

08.00 1. Internship Pro Healthy Jakarta Nurses, Midwifes, Residents, trainees Thailand Laboratory doc New Internist Research & Develop.
gram (IP):Pre& Post Program & Referral Oncology nurses consultants, Indonesia tors, laboratory fellow oncology Center of Transf
10.00
2. General Hospitals fellows of Networking scientists, labora program usion Med FKUI:
practitioner (GP) throughout HMO/HO/ HCP & tory technicians Master ,Trans Med
Indonesia others Technology
(IP&GP) (HJP, RHI (NM) (ON) (RETCFHO) THIN (LAB) (NIFO) (MTMT)
(THIN-SPEC)
08.00 IP & GP Session 9 THIN SYMPO 2 NIFO Session 9 MTMT Session 9
(STHSC, Module 9) Transfusion medi
09.00 Pain management in patients with cancers Session 1: Systemic therapy cine technology in
1. Pathophysiology: DR dr Cosphiadi Irawan Flowcytometry: 1. In breast cancer: hospital: Auto
MBC, locally transf/usion in:
2. Assessment of pain; Dr dr Andhika 1.General principles (Prof Kovit P, PhD)
advanced 1. Pre surgical
3. Management: dr Asrul Harsal, SpPD< KHOM 2. Specimen handling (PBSC, BM) (Prof Kovit) 2.in lung cancer: operation
4. Barriers to opioids: Prof Dr dr Aru Sudoyo 3. Laboratory diagnosis of acute leukemia MNSCLC, locally 2. During surgical
advanced operation (dr Elida
(Dr dr Agus Kosasih, SpPK) Marpaung,MBiomed
09.00 IP & GP Session 10 THIN Symposium 2 NIFO Session 10 MTMT Session 10
(STHSC,Module10) Advances in
10.00 Pain management in patients with cancers Session 2 Systemic therapy technology of blood
5. Case studies Flowcytometry: 1.in cervical cancer donor
1. In other hematological diseases (Prof : chemoradiation, 1. Cryoprecipitate
adjuvant. 2. Glyceroles
Kovit pattanpanyasat.PhD) (Thailand) 2. in nasopharyng 3. Others
2. In enumeration and viability of CD 34+ eal cancer: (dr Saptuti Chunaeni,
chemoradiation, MBiomed)
stem cells for stem cell therapy & HSCT / adjuvant,neo-adju
BMT (Dr dr Agus Kosasih, SpPK) vant (Module 2)
10.00 Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area)
10.15
ROOM ! ROOM 1 ROOM 1 ROOM 1 ROOM 1 ROOM 5 ROOM 2 ROOM 7
Puri Ratna Puri Ratna Puri Ratna Puri Ratna Puri Ratna Candi Kalasan1 Candi Singosari Candi Kalasan 2
SYMPOSIUM3&4 SYMPOSIUM 3&4 SYMPOSIUM SYMPOSIUM 3,4 SYMPOSIUM 3&4 TUTORIAL 4 D TUTORIAL 7 A TUTORIAL 6 D
3,4
 IP & GP SPEC NIFO RETCFHO N LAB HJP-RHI MTMT
10.15 SYMPOSIUM 3 LAB Session 9 TUTORIAL 7C, MTMT Session 11
Chronic Myeloge Session3: Clinical aspects of
11.15 Metastatic Non small cell lung cancers (NSCLC) nous Leukemias Iron chelators: blood donor
Chairman: Prof dr Abdulmuthalib, SpPD, KHOM (CML)&MPN LAB 1.When thalasse (manual&apheresis)
(Module 1): mia patients need 1. Pre donor
1. Principle of the current treatment of the metastatic NSCLC (dr Astrul Harsal,
1. BCR-abl quali it? assessment
SpPD, KHOM (Jakarta, Indonesia) tative.2. JAK-2 2. How to give in 2. Monitoring during
2. Targeted therapy of small molecules: When and how they are used in mutations children & adult? & post donation
3. Case studies 3. Case studies (Dr dr Niken Rirchi,
metastatic NSCLC ? dr Panji Irani Fianza, SpPD, KHOM (Bandung, Indonesia) (dr bambang a. Dr dr Teny Tjitras MBiomed, SpKTp)
Karsono,SpPDK) b.dr Wulyo Rajabto
11.15 SYMPOSIUM 4 LAB Session 10 TUTOriAL 7 B MTMT Session 12
CML diagnosis Emergency oncolog 1. Complications of
12.15 TINCEH (Taiwan-Indonesia Networking in a Center of Excellence in Hematology) (Module 2): y:1.Tumor lysis syn blood donor
Hematological rare diseases Gauchers disease Molecular diag drome.2.Supeior collections
nosis. 1. BCR-abl caval venous syn 2. Prevention &
1. What is Gauchers disease ? Dr dr Damayanti, SpA (K)
quantitative drome.3.Spinal me treatment
2. How to diagnose? (Pin-Wen Chen, PhD,National Taiwan Univ Hosp, Taiwan) 2. Case studies dulla compression Dr dr Yuyun
3.Case studies: When is Gauchers disease is suspected?(dr Endang Wind, SpA,K) (Prof Dr dr A Dr dr Dody Sudahramono, MSc,
Harryanto et al) Ranuhardy, SpPD SpKTp

12.15 LUNCH TIME (Candi Bentar and Pre function of Candi Singosari
13.15
ROOM ! ROOM 1 ROOM 1 ROOM 1 ROOM 1 ROOM 5 ROOM 2 ROOM 7
Puri Ratna Puri Ratna Puri Ratna Puri Ratna Puri Ratna Candi Kalasan 1 Candi Singosari Candi Kalasan 2
SYMPOSIUM 5 SYMPOSIUM 5 SYMPOSIUM SYMPOSIUM 5 SYMPOSIUM 4 TUTORIAL 4 E TUTORIAL 6 E
IP & GP SEAMOF /SPEC NIFO RETCFHO N LAB HJP-RHI MTMT
13.15 SYMPOSIUM 5 LAB Session 11 TUTORIAL 7 C MTMT Session 13
20.20 Chairperson: Prof Dr dr A Harryanto reksodiputro, SpPD, KHOM TUTOSIAL 4 F 1. Emergency in Cardio pulmonary
Diagnostic tests hemophilia? resuscitation (CPR)
20.35
14.15
1. Current management of metastatic breast cancer (MBC): Focused on systemic for Gauchers di 2. What should we during donor
chemotherapy in triple negative breast cancer seases (Pin-Wen do? When to refer? collections
Chen,Taiwan) 3. Q & A Dr dr Cosphiadi
Dr. dr Noorwati Sutandio,SpPD, KHOM (Jakarta, Indonesia) Dr dr Novie Chozie Irawan
2. Eribulin as the third, second and first cytotoxic chemotherapy choice in MBC Amalia
and Its future dr nadya
Dr.Suebpong Tanasanvimon (Thailand) Ayumulansari

14.15 HINCEH SYMPO 6 LAB Session 12 TUTORiAL 7 D MTMT Session 14

15.15 Diagnostic tests 1. Comprehen sive 1. Complications of
Myeloproliferative neoplasm (MPN): Current criteria & advances in the treatment for rare diseases care of hemophilia blood transfusions in
Chairperson: Tbd other than Gau Prof Paul recipients.2. Pre
 1. Polycythemia vera (PV) (Dr Raymond SM Wong, Chinese University of HK) chers disease Giangrande, PhD vention & treatment
(Pin-Wen (Oxfords Dr dr Tb Djumhana
2. Primary myelofibrosis (PMF) (Dr Raymond SM Wong, Hong Kong) Chen,PhD) University, UK) Atmakusuma
15.15 Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area)2.
15.30
ROOM ! ROOM 2 /ROOM 2 ROOM 2 ROOM 2 ROOM 5 ROOM 1 ROOM 7
Puri Ratna Candi Singosasri Cadni Singosari Candi Singosari Candi Singosari Candi Kalasan 1 PURi RATNA Candi Kalasan 2
TUTORIAL 1 D SYMPOSIUM 7 SYMPOSIUM 7 SYMPSOIUM 7 SYMPOSIUM 7 TUTORIAL 4 F TUTORIAL 1 D TUTORIAL 6 F
IP & GP SEAMOF/ SPEC HJP-RHI RETCFHO NIFO LAB N, ON MTMT
15.30 IP & GP Session 11 The 7th SEAMOF SYMPOSIUM-7 LAB Session 13 N, ON IP&GP MTMT Session 15
16.30 Supportive therapy 1. Laboratory dia Session 11 1. Laboratory
in cancer patients: 1. Past, present & future of systemic therapy in lung cancer gnosis of plasma Supportive therapy diagnosis of side
Nausea vomiting, (NSCLC) . Dr Daniel Tan (Singapore) cell dyscrasias: in cancer patients: effects of
diarrhea, nutrition Waldenstorm Nausea vomiting, transfusion
2. Past, present & future of systemic therapy in breast cancer;
macroglobuline diarrhea, nutrition complication in
Prof Dr Rebecca Dent mia, light chain hospitals
3. Past, present & future of systemic therapy in colorectal deposition,hea (Module 1) 2. Case studies
vy chain disease (dr Nova Hippy,
(Module 1)
cancer tbd Prof Siti Boedina MBiomed)
16.30 IP & GP Session 12 4. Past, present & future of systemic therapy in prostate cancer LAB Session 14 N, ON IP & GP MTMT Session 16
17.30 Supportive therapy tbd 1. Laboratory of Session 12 1. Blood cross
in cancer patients: molecular by Supportive therapy matching
Stomatitis &
5. Past, present & future of systemic therapy in sarcoma DNA microarray in cancer patients: incompatibilities
Infections tbd 2. Case studies Stomatitis & 2. Results of
6. Q & A (Prof Teh Bin Infections incompatibility and
Thien,Singapore) (Module 2) recommendations
(Module 2) (Dr dr Niken Ritchie)
17.30 End of day 2 scientific meetings
17.30 Candi Singosari Room
18.30 1. How to fill in Log book and Portfolio of the Internist Fellow Oncology (IFO) who has a certificate of chemotherapy from a Central Committee of ISHMO-IM (PERHOMPEDIN) and
Branches Offices of ISHMO-IM throughout Indonesia in order to get a re-certification from ISHMO IM and a certificate of competency from Collegium of Internal Medicine
17.50 (Kolegium Ilmu Penyakit Dalam / KIPD)
18.10 2. Maghrib prayer

Day 2, Saturday, November 10, 2016 Parallel Program Topics

14.15 Room 6, EXPERT MEETING of EISAI 1. Expert case reports of eribulin use in MBC of some HMO centers in Indonesia
15.45 Candi Dieng 1 + 2 2. Compiling of the eribulin use in MBC throughout Indonesia until November 2016

Day 2, Saturday, Dinner Symposium and Business Meeting

November 10 , 2016
18.30 Room 2 DINNER 1.Imatinib versus nilotinib as a first line therapy of CML with regards to molecular impacts? And past, present, and future of CML treatment
20.00 Candi SYMPOSIUM 2 Prof Kim Dong Wook, MD, PhD (Head of the International Clinical Research, St Marry Hospital, Seoul)
Singosari 2.The South Korea Indonesia Networking in Chronic Myealogenous Leukemia (CML) as a MODEL to develop a collaboration in networking
Room a. Past, present, future of the collaborations between South Korea and Indonesia (Prof Dr A Harryanto Reksodiputro,SpPD, KHOM)
b. Results of the collaboration after 8 years: Thesis of PhD programs & subspecialist program
(Dr dr Hilman Tadjoeddin, KHOM, Dr dr Ugroseno,SpPD, KHOM, Dr dr Ikhwan Rinaldi,SpPD, KHOM, dr Wulyo Rajabto, SpPD, KHOM)
20.00 BUSINESS MEETNG-2 How to strengthen and establish the SEAMOF (Southeast Medical Oncology Forum) and Networking in A Center of Excellence in Hematology between
22.30 Indonesia and other countries in SEA and EA
Topics The SEAMOF, the South Korea-Indonesia Networking, the Singapore Indonesia Networking, the Hong Kong - Indonesia Networking, the Taiwan Indonesia Networking, the Thailand
Indonesia Networking
20.00 21.00: Round table discussion of each networking: Vision, mission, strategic issues , plan of action (POA) of the next 2 5 years
Goals Centers of Excellence in Hematology and Medical Oncology in Southeast Asian Countries are established in the next two years and can join multicenter studies

Day 3. Sunday, December 11th , 2016

07.30 - Registration
ROOM ! ROOM 1 ROOM 1 ROOM 1 ROOM 1 ROOM 2 ROOM 2 ROOM 2
Puri Ratna: Puri Ratna Puri Ratna Puri Ratna Puri Ratna Candi Singosari Candi Singosari Candi Singosari
SYMPSOIUM 9 & 10 SYMPOSIUM 9 +10 SYMPO 9+10 SYMPO 9+10 SYMPO 9+10 TUTORIAL 4 TUTORIAL 4 TUTORIAL 4
08.00 1. Internship Program 1. All internists, New Internist Residents, train Laboratory The Indonesian Apheresis nurses Research & Deve
(IP): Pre & Post pediatricians,patholo fellow oncology ees, consultants, doctors , labor Apheresis Working lopment Center of
10.00
2. General practitio gists, other specialists fellows of HMO/ scientists, labor Group/IAWG,BMT Transfusion Medi
ner (GP) (IP&GP) (SPEC) SINCEH (NIFO) 2nd HO/HCP (RETCF technicians WG, Stem cell the cine FKUI (MTMT,
2nd SINCEH 2. HJP / RHI SINCEH HO) SINCEH (LAB) SINCEH rapy WG (IAWG) (AN) Session 17 & 18)
08.00 nd
The 2 SingaporeIndonesia Networking (SINCEH) SYMPOSIA, Session 1 IAWG Session 1
09.00 (SYMPOSIUM 9) Platelet and stem cell collections
Plasma cell dyscrasias 1. Platelet donor apheresis collection (dr
1. Classification of plasma cell dyscrasias (dr Ibnu Purwanto,SpPD,KHOM)(Yogya) Yanto, MBiomed)
2. Laboratory diagnosis multiple myeloma (MM) and algorithm approach when 2. Apheresis peripheral stem cell collection:
we use serum protein electrophoresis, serum and urine immunofixations, urine auto/allogeneic (dr Nadia Ayu Mulansari)
protein Bence Jones and -2 microglobulin ? Prof dr Siti Boedina, SpPK 3. Bone marrow stem cell/BMSC collection
(K)(Jakarta) (Dr dr Cosphiadi Irawan)
3. Q & A
09.00 2nd SINCEH SYMPOSIA, Session 2 (SYMPOSIUM 10) IAWG Session 2. Therapeutic apheresis
10.00 Multiple myelomas (Prof Chng Wee Joo, MD, PhD, NUH, Singapore) 1. Therapeutic plasmapheresis. leukapheresis,
1. Current diagnostic criteria of MGUS , smoldering and active MM thrombapheresis: When we use them?
2. Past, present & future of the treatment of MM: Dr dr Tb Djumhana Atmaksuma
 a.The role of bone marrow transplantation(BMT) in the continuum care of MM 2. Is plasmapheresis the first choice of
b.Beyond 10 years of bortezomib: The role in an continuum care of MM treatment in Guillain Barre Syndrome &
3. Q & A Myasthenia gravis? Dr dr Manfaluty, SpS(K)
10.00 Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area)
10.15
ROOM ! ROOM 1 ROOM 1 ROOM 1 ROOM 4 ROOM 6 ROOM 5 ROOM 7
Puri Ratna Puri Ratna Puri Ratna Puri Ratna i Candi Kalasan 1 Candi Dieng 1+2 Candi Pawon 1+2 Candi Kalasan 2
SYMPOSIUM 10 + 11 SYMPOSIUM 10+11 SYMPO 10+11 SYMPO 10+11 TUTORIAL 4 I TUTORIAL TUTORIAL 5 TUTORIAL 6 G
IP & GP 2nd The 2nd Singapore Nurses-Midwife MTMT &
SINCEH, SYMPOSIUM Indonesia Networking (NM), CN
(SINCEH): 1. SPEC NIFO RETCFHO
10 + 11
RJP-RHI 2nd SINCEH 2nd SINCEH IAWG, BMT-WG,
SYMPOSIUM SYMPOSIUM 10 LAB Session 17 STWG Hjp / uhp
10.15 The SINCEH (the Singapore-Indonesia Networking of Center of TUTORIAL 4 G Stem cell therapy NM Session MTMT Session 19
LAB Session 15 Session 1 1. Early case Donors for plasma
11.15 Excellence in Hematology) SYMPOSIA Session 3 1. Screening 1.Arterial findings of fractionations:
(SYMPOSIUM 11): tests for thrombosis: hemophilia 1. Donor assess
bleeding cases Pathogenesis (Prof 2. Prevention & ment of pre-
Advances in non-Hodgkin lymphomas (NHL)
and pre- Dr dr A Harryanto) therapy in plasmapheresis
Chairperson: tbd operation 2, Basic science of hemophilia 3. Plasmapheresis
10.15 1. Current diagnosis of NHL based on immunohistochemistry 2. Diagnosis test stem cell biology Dr dr Novie procedure
for: a. (Dr dr Cosphiadi I) Chozie Amalia 3. Surveillance post
10.40 (IHC) staining (Prof Tan Soo Yong, MD,PhD) (Singapore) hemophilia A, 3. Systematic revi dr Findy plasmapheresis
10.40 2. Current management: R-CHOP standard versus others & R-sal hemophilia B, ew/meta-analysis: Prasetyawaty (dr Auda S Aziz)
11.05 vage regimens & the role of bendamustin and rituximab / BR) von Willebrand a. Acute MCI (dr Saptuti
b. F VIII & F IX (Prof Dr dr Idrus Chunaeni,MBomed
among other rituximab combinations (Daryl Tan Chen Lung,MD) inhibitors (Prof Alwi) )
(Singapore) Dr dr Rahajuning
sih Dharma
11.05 3. Q & A
11.15
11.15 The SINCEH SYMPOSIA Session 4 (SYMPOSIUM 12): TUTORIAL 4 H Stem cell therapy NM Session MTMTSession 20
LAB Session 16 Session 2 1. Early case fin Blood products for
12.15 Advances in Hodgkin lymphomas (HL) Laboratory tests Systematic review: dings of thala patients who are
Chairperson: tbd for anticoagu Stem cell therapy ssemia major in undergoing hema
lants in: children. 2. Pre topoietic stem cell
11.15 1. Current diagnosis of HL based on immunohistochemistry (IHC)
monitoring: b. End stage car vention/ screen transplantations
11.40 staining (Prof Tan Soo Yong, MD,PhD) (Singapore) a. aPTT diac diseases (Prof ing program (HSCT/BMT):Leuko
11.40 2. Current management of HL: The role of brentuximab vedotinin b. aXa Dr dr T Santosos) 3. Case studies depleted/ irradiat
c. PT / INR 3. PAD in DMDR( (Dr dr Pustika ion of allogeneic
12.05 advanced and earliar stage of HL (Prof Lim Soon Thye, MD) d. case studies (Dr dr M Yunir) Amalia) BMT donors
12.05 (Singapore) Por Dr dr Rahaju (dr Wulyo = dr Nadia AM
12.15 Q&A ningsih dharma Rajabto) = dr Yanto

12.15 LUNCH TIME (Pre function of Candi Singosari & Candi Bentar)
13.15
ROOM ! ROOM 2 ROOM 2 ROOM 2 ROOM 4 ROOM 6 ROOM 1 ROOM 2
Puri Ratna Candi Singosari Candi Singosari Candi Singosari Can di Candi Dieng 1+2 Puri Ratna Candi Dieng 1+2
TUTORIAL 1 E SEMINAR-3 SEMINAR 3 SEMINAR 3 TUTORIAL 4 K TUTORIAL TUTORIAL 1 E TUTORIAL ?

1. Internship Program
(IP): Pre & Post
2. General practitioner
(GP) (IP&GP) All participant NIFO RETCFHO LAB BMT Group NM , ON MTMT
13.15 IP&GP Session 13 SEMINAR 3, Session 1: TUTORIAL LAB 4 Bone marrow/He NM , ON IP/GP Apheresis
(VTE Module 1) TUTORIAL 4 J matopoietic stem Session 13 machines , kit and
14.15 Cancer systemic therapy/Anti-cancer drugs:
1. Deep vein LAB Session 19 cell transplanta (VTE Module 1) solutions:
thrombosis (DVT):
Originator/Inovator, Me-too, bio-similar, gene Platelet function tion (BMT/ HSCT) Deep vein 1. How the work ?
tests: Session 1: 2. How to operate
acute and chronic rics (OIMBG) thrombosis
1. Platelet Infection control them
DVT Chairperson: Prof Dr dr Ary Harryanto aggregation program:
(DVT): acute 3. How to maintain
Dr dr Lugyanti Reksodiputro, SpPD, KHOM 2. Platelet 1. Prophylaxis , em and chronic them
Sukrisman, SpPD, function pirical & definite DVT 4. What we do if
1. What doctors know about OIMBG ? (Dr dr assessment anti fungals of Dr dr Lugyanti we have trouble o
KHOM
2. Case studies: Djumhana Atmakusuma, SpD, KHOM) (PCA) recipients Sukrisman, those machines
dr Inolyn Pandjaitan 2. What the differences among those OIMBGs? 3. Case studies 2.fungal surveil SpPD, KHOM (Hemonetics)
(Dr dr Nadzwa lance in patients & 2. Case studies: (Optia)
dr Edison YP What about the policy of OIMBG In USA (FDA) , Zamalek, environment (Comtec)
Saragih dr Inolyn
in European Union / UO (EMEA), in England SpPK/K) 3. Q & A
- Dr Louis Chai,
Pandjaitan
(NICE) (Prof dr Iwan Dwiprahasto, M.Med. Sc, dr Edison YP
Infectios Disease,
PhD) (Yogyakarta) NUH, Singapore) Saragih
3. Q & A -Dr dr Djumhana A
14.15 IP & GP Session 14 SEMINAR 3, Session 2: Cancer systemic therapy/ Platelet MT/HSCT NM Session 214 Test machines/
(VTE Module 2) antibody tests Session 2. GP Session 14 machine trials:
15.15 Anti cancer drugs (OIMBG)
1. Pulmonary 1. MAIPA Infection control (VTE Module 2) 1. Hemonetics
Moderator: Prof Dr Abdulmuthalib, SpPD, KHOM 2. HLA platelet program: 2. Optia
embolism (PE) Pulmonary
1. Monoclonal antibodies (MAb): Biosimilars versus antibodies 1. Prophylaxis , 3. Comtec
Prof Dr dr Karmel L embolism (PE)
originator biologic products (PK&PD in comparison) (Dr dr Andhika empirical and de
Tambunan Rachman) finite antibiotics
2. Case studies (Prof Dr dr Rianto Setiabudy, SpFK) (Jakarta)
(Dr dr Ni Ken of recipients
dr Eka Widya 2. MAbs & small moleculs (SM) Ritichie) 2. Environment
Khorinal a. MAb biosimilar vs MaB originator biologic bacterial
dr Maya products surveillance
3. Q & A
 b. SM generics vs SM originator - Dr Louis Chai,
Infectios Disease,
2.1. PROS MAb biosimilar & SM generics (dr
NUH, Singapore
Trinugroho Heri Fadjari, SpPD, KHOM) (Bandung) - Dr dr Dody
2.2. CONS MAb biosimilar & SM generics (dr Johan Ranuhardy
Kurnianda, SpPD, KHOM) (Yogyakarta)
Refreshment Break & Poster Session (Pre Function Puri Ratna in Exhibition/Expo Area
ROOM 2 ROOM 2 ROOM 2 ROOM 4 ROOM 5 ROOM 6 ROOM 7 ROOM 7
Puri Ratna Candi Singosari Candi Singosari Candi Bentar Candi Pawon Candi Dieng 1+2 Candi Kalasan 1+2 Candi Kalasan 1+2
IP / HJP (UHP) SEMINAR 3 SEMINAR 3 TUTORIAL 3 F 1+2 TUTORIAL TUTORIAL 6 H TUTORIAL 6 H
JAMHEMOF Citywide TUTORIAL 5
meeting
IP - GP All participants RETCHFO NIFO N,M,ON,AN, BMT Group LAB MTMT
CN
15.15 IP/HJP (UHP) SEMINAR 3, Session 3 NIFO Session 11 Emergency cases BMT/HSCT TUTORIAL 4 K LAB MTMT
JAMHEMOF City wide Systemic therapy in hematology- Session 3.
16.15 Cancer systemic therapy/ Anti Session 23
meeting: Case in: oncology Infection control
discussions of Hemo cancer drugs (OIMBG) 1. pancreatic Session 1: program: GLP (Good laboratory
philia, Hemato-On cancer Tbd 1. Clean rooms:
Chairperson: Prof dr Nuzirwan practice) in blood banking &
cology,Thalassemia 2. soft tissue conditions,systems
(HOT) patients of 5 Acang, SpPD, KHOM sarcoma & (Dr dr Hilman & equipments, stem cell banking
Regional referral 1. BPOM regulations of OIMBG osteosarcoma tadjoeddin) water treatment (LITANG KEMKES: Dr Ketut)
hospitals of DKI 3. Case studies 2. Maintenance &
Jakarta Raya
(tbd) infection surveil
(the Healthy Jakarta 2. Ministry of Health RI lance of bacteria &
Program /Urban regulations of OIMBG (tbd) fungi| 3. Q & A
helath Program) + the (Tbd : Malaysai)
ISHTM, Jakarta 3. Hospital pharmacy
Branch) installation s policy of OIMBG
(Dr Dra Rizka Andalusia NP, Apt)
16.15 IP/JAMHEMOF City SEMINAR 3 NIFO Session 12 Emergency cases BMT/HSCT MTMT Session
wide meeting: 1. Case Systemic therapy in hematology- Session 4: HSCT,
17.15 Session 4 Good manufactur ing
discussions of HOT in: oncology Nursing care in
patients of 5 Regional Panel discussion 1. Bladder cancer patients infection control products (GMP) in blood
referral hospitals of Panelists: All speakers, all 2. ovarian cancer Session 2. program: patients,
banking & stem cell banking
DKI Jakarta Raya moderators in Session 1,2 & 3 3. Case studies Tbd foods, rooms,
2.Suggestions to Intern (Tbd) (dr dr Nugroho medications, blood (BPOM:Dra Nurmah)
ship program Parayogo) products
(HJP/UHP & the ISHTM (Nr Linda Amiaty,
Jakarta Branch) SkP)
17.15 - End of day 3 sessions (End of The 2nd ISMI-HOTTI 2016)
Day 3, Sunday, November 11, 2016 Parallel Program Topics
12.15 Room 3, TUTORIAL 8 TAKEDA Cross-talk between Pathologists and Hematologists on Hodgkins
13.45 Candi Pawon 1 + 2 Advances in the diagnosis and treatment of Hodgkin lymphoma lymphoma with regards to current diagnosis and its consequences to the
treatment

Day 3, Sunday, November 11, 2016 GALA DINNER of ALUMNI, Department of Internal Medicine Objectives
19.00 Room 1 DEDICATED to OUR BELOVED ALMA MATER. Department of INTERNAL Fund raising to support the activities and program of Department of
23.00 Puri Ratna MEDICINE, Medical Faculty, University Indonesia, Dr Cipto Internal Medicine, University Indonesia
Mangunkusumo General Hospital
Organizer The Indonesian Foundation in the Development of Hematology,
Oncology and Transplantation (IFDHOT)